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Abstract
Cystatins are reversible, tightly binding inhibitors of cysteine proteases. Filarial cystatins have been
ascribed immunomodulatory properties and have been implicated in protective immunity. To
continue exploration of this potential, here we have determined the sequence, structure and
genomic organization of the cystatin gene locus of A. viteae. The gene is composed of 4 exons
separated by 3 introns and spans ~2 kb of genomic DNA. The upstream genomic sequence contains
transcriptional factor binding sites such as AP-1 and NF-Y, an inverted CCAAT sequence, and a
TATA box. To investigate sites of cystatin expression, Caenorhabditis elegans worms were
transformed by microinjection with the putative promoter region and the first exon of the A. viteae
cystatin gene fused to the reporter GFP. In transgenic worms fluorescence was observed in the
pharyngeal and rectal gland cells suggesting that cystatin is secreted. Additionally, A. viteae cystatin
was expressed in C. elegans to explore its potential as an expression system for filarial genes.
1. Introduction
Filarial nematodes reside among others in the lymphatic
vessels or the subcutis of their vertebrate hosts, where they
often persist for many years in spite of an array of immune
effector mechanisms. The persistence of the parasites has
in part been attributed to the fact that they interfere with
the regulation of immune responses and induce anti-
inflammatory immune reactions [1]. One of the parasite-
derived molecules described in this context is the filarial
excretory/secretory protein cystatin. Cystatins are reversi-
ble, tightly binding inhibitors of cysteine proteases [2].
Cystatin of Onchocerca volvulus was first described by Lust-
igmann et al. [3]. Since then studies on cystatin of other
parasitic nematodes such as the rodent filaria Acan-
thocheilonema viteae [4], Brugia malayi [5,6], Litomosoides
sigmodontis [7], Nippostrongylus brasiliensis [8] and O. volvu-
lus [9] have revealed that it is a modulator of the host
immune response. Cystatins of parasitic nematodes have
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inhibition of proteases and induction of cytokines [10-
13] and can thus be considered as a major pathogenicity
factor. Cystatin of O. volvulus [14] and A. viteae (unpub-
lished) have also been tested as vaccine antigens.
Functional studies on cystatin so far have relied on recom-
binant proteins expressed in E. coli [4]. The investigation
of its role could however be simplified by over-expression,
knock-down of the protein by RNAi [15] or production of
knock-out mutants. Although transient transfection stud-
ies have been reported in parasitic nematodes [16,17],
they are still in their infancy and the established C. elegans
system offers itself as a proxy model for functional studies
of filarial promoters and antigens. Krause et al. [18]
reported expression studies of O. volvulus GST-1a in C. ele-
gans and Kampkötter et al. [19] have shown that O. volvu-
lus GST-3 overexpressed in C. elegans could confer it
increased resistance to oxidative stress. Similarly, a study
by Redmond et al. [20] showed that transgenic C. elegans
were able to express a glycosylated vaccine candidate pro-
tein of the gastrointestinal nematode of ruminants,
Haemonchus contortus. Expression of vaccine candidate
antigens in C. elegans could therefore represent a way for-
ward to produce recombinant proteins that are correctly
folded and bear nematode specific post-translational
modifications, which might be relevant for inducing pro-
tective immune responses in vertebrate hosts.
C. elegans has been exploited as a heterologous transfor-
mation system to examine the activity and specificity of
parasitic nematode gene promoters [21,22]. Beyond a
mere role as an expression host, studies with transgenic C.
elegans that express the reporter gene GFP under the con-
trol of the filarial cystatin promoter could also give an
insight as to the localization and hence to the so far
unknown roles of cystatin in nematodes. Apart from its
role as an immunomodulator, cystatin has been hypothe-
sized to regulate proteases that are involved in processes
such as moulting, and it has been shown that inhibition
of cysteine proteases with chemicals indeed interferes
with moulting of O. volvulus [3,23]. It is therefore possible
that the moulting process could be inhibited in C. elegans
expressing filarial cystatin, or that another phenotype
results. Moreover, expression and release of cystatin in
transgenic parasitic nematodes could alter their interac-
tion with the host, e.g. inducing an increased down-regu-
lation of inflammatory immune responses.
As a prelude to such functional studies we analyzed the
genomic organization of the cystatin of A. viteae (Av17)
and defined its promoter elements. We further demon-
strated that the Av17 promoter is functional in C elegans
and compared the expression of the cDNA and the
genomic sequence of Av17 in C. elegans.
2. Material and Methods
2.1 Maintenance of C. elegans strains
Wild type C. elegans (N2 var Bristol), phaI (e2123)
mutants and transgenic worms were cultured on Nema-
tode Growth Medium (NGM) plates seeded with E. coli
OP50 and maintained as described [24]. Animals were
cultured at 25°C (N2 var Bristol and transgenic worms) or
at 15°C (phaI mutants).
2.2 Screening of an A. viteae genomic library and isolation 
of an Av17 clone
An A. viteae genomic library which was constructed in λ-
dash was screened by DNA-DNA hybridization using a
PCR product of 405 bp amplified from Av17 cDNA (Gen-
Bank Accession # L43053) with primers (Av17fw, 5'-GTT
TTG GTG CGC TGT GAA-3'; Av17rv, 5'-CAC TGA TGA
GAG TAC TTC-3') spanning the region from bp 89 to bp
493 of the cDNA. PCR amplification was performed
under the following cycling conditions: 94°C for 5 min;
35 cycles of 94°C for 45 sec, annealing for 1 min at 58°C,
and extension at 72°C for 2 min, with a final extension at
72°C for 10 min. The resulting product was purified by
separation through a 1% agarose gel and DIG-labelled
with the DIG High Prime DNA labelling Kit (Roche). Pos-
itive clones were re-screened by PCR using combinations
of the λ-dash universal primers T3 and T7 and the Av17
reverse primer. Cycling conditions were: 94°C for 1 min;
30 cycles of 94°C for 45 sec, annealing for 1 min at 53°C,
and extension at 72°C for 2 min, with a final extension at
72°C for 20 min. A product of approximately 2800 bp,
which was amplified using T3 and the Av17 reverse prim-
ers was subcloned into pGEM-T Easy (Clontech) and
sequenced.
2.3 Synthesis of A. viteae cDNA
To generate cDNA of A. viteae, worms were disrupted by
grinding in liquid nitrogen and then suspended in lysis
buffer (RNAeasy RNA Extraction Kit, Qiagen). Total RNA
was extracted according to the manufacturers instructions.
After RNA isolation, any residual DNA contamination was
removed by digestion with RNAse-free DNAse (Promega).
The RNA was precipitated to remove the DNAse, dissolved
in RNAse-free water, and used as a template for oligo-(dT)
primed reverse transcriptions, with Moloney Murine
Leukemia Virus H (-) Point Mutant RT (Promega). The
cDNA synthesized was used for PCR reactions with differ-
ent primers.
2.4 Sequence analysis
Sequence analysis was performed using the ABI Dye Ter-
minator chemistry. The cloned fragment of the A. viteae
gDNA spanning the putative 5' upstream genomic
sequence of cystatin was analyzed for the presence of pro-
moter elements and transcription factor binding sites by
using the PromoterInspector and MatInspector publicPage 2 of 10
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ware, Braunschweig, Germany).
2.5 Construction of Av17 promoter:reporter plasmids
For transfection of Cos7 cells, the pGEM-T plasmid con-
taining the isolated genomic clone was used as a template
in a PCR reaction to amplify the upstream genomic region
using the plasmid-specific SP6 and a KpnI linked clone-
specific reverse primer (Av17rvKpn, 5' TAT CCG GTA CCA
TCG TCG TTA GCT TTG TTT 3'). The product was digested
with SacI and KpnI and ligated into pEGFP-N1 (Clon-
tech). The resulting plasmid was digested with SacI and
AflII. The 1710 bp fragment encoding the potential Av17
promoter, EGFP and the SV40-poly A was purified by aga-
rose electrophoresis and ligated into pSL1180 (Pharma-
cia). To construct a promoter-less negative control
plasmid, pEGFP-N1 was digested with EcoRI and AflII. The
1010 bp fragment comprising the reporter gene and the
SV40-polyA was then ligated into pSL1180. As positive
control in transfection studies pEGFP-N1 was used.
To construct a Av17 promoter plasmid for the transforma-
tion of C. elegans, the pGEM-T plasmid containing the iso-
lated genomic clone was used as a template in a PCR
reaction to amplify the putative promoter region together
with the first exon of Av17 using the specific primers
(prAvfw, 5'-CCC AAG CTT TAA CCC TCA CTA AAG GGA-
3' and prAvrv, 5'-AAC TGC AGA TTG CGT TCC TGC CAT
CC-3'). The product was cloned into the vector pPD 95.77
(Fire lab kit, 1995), in-frame with the reporter gene GFP
to obtain pPrAvGFP.
2.6 Construction of plasmids for expression of Av17 in C. 
elegans
The Av17 cDNA and the pGEM-T clone containing the
genomic sequence of Av17 were used as templates in PCR
reactions with primers that incorporated a NheI restriction
site at the 5' end of the sequence (Av17fwNhe, 5'-TAT TCA
GGT AGC ATG ATG TTG TCA ATA AAG-3') in conjunction
with a primer that incorporated a C-terminal 6X His tag
and a KpnI restriction site at the 3' end (Av17rvHisKpn, 5'-
TAT TCA CGG TAC CTC AAT GGT GAT GGT GAT GGT
GAT GCA CTG ATG AGA GTA C-3'). The PCR products
were cloned into the vector pPD49.83, which contains the
C. elegans hsp16/41 promoter and a synthetic intron, to
obtain p49Av17c (Av17 cDNA) and p49Av17g (Av17
gDNA). Protein expressed under the control of this pro-
moter on heat shock is targeted to the gut cells of trans-
genic worms [25].
The cDNA sequence of Av17 was also amplified using the
specific primers, 5'-TAT TCA GCT AGC ATG CAC CAT
CAC CAT CAC CAT ATG ATG TTG TCA ATA AAG-3'
(Av17fwHisNhe) incorporating NheI sequence and an N-
terminal 6XHIS tag and 5'-TCC CCC CGG GTC ACA ATG
TAC TTT A-3' (Av17rvUTRSma) incorporating the 3'UTR
of the Av17 gene and SmaI restriction site. The product
was cloned into the vector pPD103.05 to obtain
p103Av173'. This plasmid was chosen since the let-858
promoter ubiquitously expresses in all C. elegans tissues
[26].
2.7 Transformation of Cos7 cells
Cos7 cells were maintained in RPMI 1640 (Biochrom)
supplemented with 10% FCS (Biochrom) under standard
tissue culture conditions and were transfected using lipo-
fectamin reagent (Invitrogen). Cells were plated out (105
per well) in 12-well plates 24 h prior to transfection. Two
µg of the desired plasmid and 8 µl lipofectamin were
resuspended in 100 µl serum-free medium separately.
After 30 min incubation at room temperature (RT) the
solutions were mixed and incubated for another 30 min at
RT. To this, 800 µl serum-free medium was added and
applied to the cells. After 6 h of incubation under standard
tissue culture conditions the transfection reagent was
removed and the cells were maintained in complete RPMI
1640 before microscopic examination after 48 h.
2.8 Transformation of C. elegans
For promoter studies, young adult hermaphrodite wild-
type (WT) worms were immobilized on agarose pads
overlayed with mineral oil and the construct pPRAvGFP
along with the marker plasmid pRF4 (a kind gift from
James M. Kramer, Northwestern University Medical
School) was microinjected into the gonads at a concentra-
tion of 100 ng/µl. The injection was done at a pressure of
460 psi using femtotips (Eppendorf, Germany). The trans-
formation buffer contained 2% w/v PEG 6000, 20 mM
KH2PO4 and 3 mM potassium citrate. The marker plasmid
confers transgenic worms with a roller phenotype. Only
worms of the second and subsequent generations, which
showed both the roller phenotype and GFP expression
were used for further analysis of the Av17 promoter. As a
negative control, WT worms were microinjected with
pRF4 and promoter-less pPD95.77.
For the expression of Av17, C. elegans, pha-1mutants (e-
2123) were transformed by microinjecting the constructs
p49Av17c, p103Av173' and p49Av17g into the gonads
together with the marker plasmid pBX at a concentration
of 100 ng/µl each. The transformed worms were selected
by their ability to survive and reproduce at 25°C. The
selected worms 103cAv173', 49cAv17 and 49gAv17 were
maintained as discrete lines at 25°C. Integration of the
extrachromosomal arrays was achieved by gamma irradi-
ation of the transgenic worms with 35 Gy. The progeny of
these worms was then screened for 100% transmittance to
obtain lines with chromosomally integrated transgens. To
verify if the transformed C. elegans contained the Av17
construct, single worm PCR was done on the F2Page 3 of 10
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gle worms were picked from NGM plates and suspended
in 2.5 µl of lysis buffer (50 mM KCl, 10 mM Tris-HCl pH
8, 2.5 mM MgCl2, 0.45% w/v Nonidet P 40. 0.45% v/v
Tween 20, 0.1% gelatin and 200 µg/ml Proteinase K) and
frozen on dry ice for 20 min. The samples were then incu-
bated at 60°C for 1 h for protein digestion and at 95°C for
15 min to inactivate Proteinase K. The resulting DNA was
mixed with PCR master mix, cycling conditions were
94°C for 5 min, followed by 35 cycles of 94°C for 1 min,
57°C for 1 min, and 72°C for 1 min and a final extension
of 72°C for 10 min. The products were resolved on 1%
agarose gel.
2.9 Microscopy
Light and fluorescence microscopy observations for EGFP
detection in Cos7 cells were made using a Zeiss Axioplan
fluorescent microscope (Oberkochen, Germany) with a
blue (number 487909) excitation filter set. The transgenic
C. elegans worms with promoter-reporter constructs were
immobilized on agarose pads and observed using a Leica
Confocal Microscope (TCS SP2) (Heidelberg, Germany).
2.10 Analysis of DNA transcription
Transcription of the injected construct was analyzed by
RT-PCR using total RNA prepared from 0.5 mg wet weight
of transformed worms (103Av173', 49cAv17 and
49gAv17) as described above. Transgenic lines 49cAv17
and 49gAv17 were given a heat shock at 33°C for 3 h
before total RNA isolation. The synthesized cDNA was
used as template in a PCR reaction using Av17 specific
primers (Av17fwNhe and Av17rv, see above). Amplifica-
tion from non-transgenic worms was included as control.
PCR was performed with the following thermal cycling
conditions: 94°C, 1 min, 30 cycles of 94°C for 1 min,
annealing 1 min 57°C, and extension at 72°C for 2 min,
final extension 72°C for 10 min. The products were sepa-
rated on 1% agarose gel.
2.11 Analysis of the expression of Av17 in transgenic C. 
elegans lysate
Transgenic worms were grown in large numbers in NGM
liquid cultures at 25°C with E. coli OP50 as a source of
food. Worm line with the Av17 gene downstream of the
inducible hsp promoter (49cAv17) was given a heat shock
at 33°C for 3 h. The main contaminants from the nema-
tode culture were cleaned by centrifugation through 60%
sucrose in 0.1M NaCl [27]. The worms were frozen in liq-
uid nitrogen and homogenized with a mortar and pestle
in lysis buffer (20 mM NaH2PO4, 300 mM NaCl, pH 7.4).
The lysate was separated on a 14% SDS-polyacrylamide
gel. Western Blot analysis was performed as described
[28]. The blot was incubated with a 1:5000 dilution of
monoclonal anti-His mouse antibody (Qiagen, Germany)
and alkaline phosphatase coupled goat anti-mouse anti-
body diluted 1:5000 was used as conjugate.
Furthermore, the progeny of the transgenic worms
expressing Av17 constitutively (103cAv173') was quanti-
fied and compared to the uninduced transgenic worms
with Av17 downstream of hsp promoter (49cAv17).
Young adult hermaphrodite (six of each) worms were
transferred to NGM plates and the number of eggs and of
larvae at every molt were quantified.
3. Results
3.1 Isolation of a genomic Av17 clone
After screening of ~10,000 plaques of an A. viteae λ-dash
genomic library, a positive clone (gAv17) was obtained.
The insert of gAv17 was ~2.8 kb in length, and when
sequenced it was found to include the entire Av17 gene.
Comparison to the published cDNA sequence of the A.
viteae Av17 revealed that the genomic sequence is com-
prised of 702 bp of the putative promoter region, 4 exons
of 166 bp, 158 bp, 51 bp and 97 bp, interspersed by 3
introns of sizes 222 bp, 158 bp and 1020 bp, followed by
191 bp of 3' untranslated sequence (Fig. 1).
Several putative regulatory sequences could be identified
by computer analysis in the 702 bp upstream genomic
sequence (Fig. 1). A putative TATA-box was located at
position -296. Consensus recognition sites for the tran-
scription factors NF-Y and AP-1 were identified at posi-
tions -37, -353 and -583, respectively. An inverted CCAAT
box was located at position -603.
3.2 Functional studies of Av17 promoter
The putative promoter region of 702 bp was capable of
promoting transient expression of the reporter EGFP in
mammalian cells. EGFP fluorescence was detected in 5 %
of Cos7 cells transfected with the promoter-EGFP con-
struct (data not shown) with the same intensity as the pos-
itive control. Cos7 cells transfected with a promoter-less
control plasmid did not show any EGFP fluorescence.
3.3 Promoter studies in transgenic C. elegans
C. elegans was used as an heterologous system to analyze
the ability of the upstream genomic sequence of Av17 to
promote the expression of the reporter gene, GFP. The
promoter construct was microinjected into the gonads of
young wild type C. elegans together with the marker plas-
mid. Transgenic animals from three transformed lines
were examined. All the lines showed GFP expression in all
stages of the worms, L1, L2, L3 and adults, but not in the
eggs. Strongest expression was observed in the gland cells
of the pharynx, which consist of 2 cells (g1 and g2; Fig.
2A,B). Expression of GFP was also observed in the rectal
glands (Fig. 2C,D), which consists of three large cellsPage 4 of 10
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lumen just posterior to the rectal valve.
3.4 Transformation of C. elegans with A. viteae cystatin
The temperature sensitive pha I mutant of C. elegans was
used for microinjection experiments to facilitate selection
of the transgenic worms expressing Av17. The transcrip-
tion factor pha-1 is required for the morphogenesis of the
pharynx [29,30]. In the pha-1 mutant worms the pharynx
fails to undergo differentiation and the mutation inter-
feres with the embryonic development at 25°C making it
easier for the selection of transgenic worms, that are co-
transfected with the rescue plasmid. Transgenic worms
lines, 103cAv173' (injected with p103Av17), 49cAv17
(injected with p49Av17c) and 49gAv17 (injected with
p49Av17g) were established and maintained as discrete
lines. In order to integrate the plasmid constructs into the
genome, worms were exposed to γ-irradiation and sub-
jected to another round of screening. The F2 and subse-
quent generations of transgenic lines were used for further
analysis. Single worm PCRs to test for the presence of
injected constructs showed that the worms (49cAv17,
103cAv173' and 49gAv17) were transgenic. No product
was amplified from the pha-1 control worms (Fig. 3A).
3.5 Transcription and translation of Av17 in C. elegans
The transcription of Av17 in C. elegans was shown by RT-
PCR. A 475 bp product consistent with the predicted size
of the coding region was obtained from the clones con-
taining the cDNA sequence of Av17 (Fig. 3B, lane 2). In
worms with the genomic sequence (49gAv17), transcripts
of a larger size were amplified, which on sequencing were
found to include a part of the first intron (Fig. 3B, lane 3).
Further analysis revealed that the conserved intron splice
donor site AG/gt was apparently read through and the sec-
ond AG/gt downstream in the first intron was recognised
as the splice donor site. The remaining introns were
spliced out correctly to obtain a transcript of 626 bp (Fig.
4, ii) including 152 bp of the first intron, instead of a tran-
script size of 475 bp, if splicing had occurred correctly. No
amplification product was obtained from the control pha-
1 worms.
In a western blot, anti-His antibodies specifically recog-
nized a band of 17 kDa in the transgenic C. elegans lines
103cAv173' and 49cAv17 expressing Av17 constitutively
and under heat shock (Fig. 3C). No expression was seen in
pha-1 control worms and 49gAv17.
In worms expressing Av17 constitutively (103cAv173') of
20 ± 15.9 eggs only 5.2 ± 3.8 developed to adults. The
reduction in the ability of the eggs to develop to adults is
significant (p < = 0.0129) when compared to worms
transformed with Av17 downstream of hsp promoter but
uninduced, where of 24 ± 16.4 eggs, 19 ± 10.2 developed
to adults (data not shown).
4. Discussion
In this study, we have determined the entire genomic
organization and the sequence of A. viteae cystatin gene.
We identified putative promoter elements in the upstream
genomic sequence and used C. elegans as a heterologous
system to determine the localization of Av17 in the worm
tissues. We have also expressed the parasite protein in C.
The nucleotide sequence of Acanthocheilonema viteae cystatin gene showing the 5' upstream genomic sequence, four exonsint rr pt d by three i trons and the 3' UTRFigu e 1
The nucleotide sequence of Acanthocheilonema viteae cystatin 
gene showing the 5' upstream genomic sequence, four exons 
interrupted by three introns and the 3' UTR. The putative 
TATA box and transcription factor binding sites (CCAAT 
box, two AP-1 binding sites (CCAAT) and one NF-Y binding 
site (TGAGTCA)) are boxed. The sequence highlighted in 
gray shading corresponds to the 5' upstream genomic 
sequence and 3' UTR. Exons are in capital letters. The start 
ATG and the stop TGA are italizised.Page 5 of 10
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nematode as a system for the expression of parasitic nem-
atode proteins.
To date, we have isolated and characterized one cystatin
gene from A. viteae, although 2 isoforms of cystatin have
been reported in B. malayi [6] and in C. elegans [13]. In C.
elegans the cystatins are also secreted as in the parasitic
worms but they do not have the same immunomodula-
tory properties [13], instead they could play a role during
moulting. RNAi of C. elegans cystatins does not show vis-
ible phenotypes, possibly because their loss of function is
compensated by other protease inhibitors.
The genomic sequence of Av17 contains 3 introns of sizes
222 bp, 158 bp and 1020 bp respectively. All of the
introns in the Av17 gene have a consensus splice donor
site, gt and a consensus splice acceptor site, AG [31]. The
702 bp upstream genomic sequence of Av17 contains a
TATA box, an inverted CCAAT box sequence and
Expression pattern of the Av17promoter::GFP construct in transgenic Caenorhabditis elegansFigure 2
Expression pattern of the Av17promoter::GFP construct in transgenic Caenorhabditis elegans. (A) Fluorescence staining in the 
pharynx of a worm transformed with the Av17promoter::GFP fusion construct. The pharynx contains two classes of gland 
cells, g1 (two cells) and g2 (two cells) in the second bulb of the pharynx. The g1 cells extend three cuticle-lined ducts anteriorly 
within the narrow pharyngeal nerve cords, two of which pass through the isthmus and empty into the pharyngeal lumen near 
the first bulb and the dorsal g1 duct empties near the anterior end of the pharynx. The g2 cells extend shorter ducts, which 
empty into the lumen of the second bulb. (C) Fluorescence staining in the rectal gland cells (rectD, rectVL, rectVR) in the pos-
terior of the same worm as in (A). These cells connect to the intestinal lumen just posterior to the rectal valve. (B) and (D) 
Bright field microscopy of (A) and (C), respectively.Page 6 of 10
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AP-1 and NF-Y. Binding sites for the transcription factor
AP-1 are found in numerous mammalian immunoregula-
tory and inflammatory genes [32]. In the promoter region
of the mammalian salivary Cystatin S the presence of an
AP-1 binding site has been suggested to play a role in the
regulation of expression [33]. Among parasites, AP-1 has
been shown to be involved in the transcriptional regula-
tion of Schistosoma mansoni calreticulin [34]. Upstream
genomic sequences of C. elegans cystatins do not have
transcription factor binding sites comparable to Av17.
Additional studies on the promoter elements are required
to determine the role they play in the regulation of cysta-
tin. The putative promoter sequence was however able to
drive GFP expression in Cos7 cells, demonstrating that it
is functional.
(A) Single worm PCR of transgenic worms, 49cAv17 and 49gAv17, containing the cDNA (lane 1) and genomic sequence (lane 2) of A. viteae cystatin respectiv lyFigure 3
(A) Single worm PCR of transgenic worms, 49cAv17 and 49gAv17, containing the cDNA (lane 1) and genomic sequence (lane 
2) of A. viteae cystatin respectively. (B) RT-PCR analysis of transcripts from transgenic worms, 49cAv17 and 49gAv17, contain-
ing the cDNA (lane 2) and genomic sequence (lane 3) of A. viteae cystatin respectively. Negative control with wild type C. ele-
gans in lane 4 and marker in lane 1. (C) Western Blot with anti-His antibodies. Lane 1: Transgenic C. elegans expressing Av17 
constitutively (103cAv173') ; Lane 2: Transgenic C. elegans (49cAv17) expressing Av17 induced by heat shock ; Lane 3: pha-1 
control wormsPage 7 of 10
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lines of C. elegans obtained by microinjection of the
Av17promoter::GFP construct. We observed GFP
expression in all larval stages and the adults of the trans-
genic C. elegans, showing that Av17 is temporally
expressed as in the parasitic worms [4]. The strongest
expression was observed by light microscopy in the g1 and
g2 gland cells of the pharynx and the rectal gland cells of
transgenic C. elegans. However, immunostaining by indi-
rect immunofluorescence using anti-Av17 antibodies
localized Av17 in A. viteae and using anti-C. elegans cysta-
tin antibodies localized cystatins in C. elegans to the hypo-
dermis and in developing oocytes and embryo
(unpublished own data). It is possible that the expression
in pharyngeal and rectal glands also occurs in filarial
worms, but as these nematodes cannot be transformed
with reporter gene constructs as yet, an analysis of expres-
sion in these glands would require extensive ultrastruc-
tural studies. The immunolocalization by indirect
immunofluorescence in the hypodermis and in develop-
ing stages, i. e. in compartments that were not stained by
reporter gene expression, suggests immunolocalization
might be more sensitive than reporter gene expression.
Alternatively, it is possible that the Av17 promoter
sequence used may be incomplete and requires additional
regulatory elements to drive stronger expression to the
hypodermis. The inability of the C. elegans transcription
machinery to read filarial regulatory sequences correctly
also cannot be ruled out. Future expression analysis of the
promoter sequence of C. elegans cystatins would resolve
this.
The expression of the reporter gene in pharyngeal and
gland cells, i.e cells that release products to the exterior
environment, is compatible with the earlier shown and
suggested functions of cystatin as an immunomodulator
[13] and in moulting [37], respectively. As these gland
cells are stimulated synchronously with pharyngeal
pumping activity, the question arises whether cystatin has
a role in digestion. Generally, in C. elegans the gland cells
have been proposed to store digestive enzymes since
digestion and absorption of nutrients take place in the
gut. However, in filarial nematodes transcuticular trans-
port is regarded as the main route for the absorption of
nutrients [36]. This suggests that Av17 in filarial nema-
todes may not be involved in the regulation of digestive
proteases. Instead filarial cystatin may have evolved to
become an immunomodulator that is permanently
secreted by the parasites. This would be in line with the
observation that molecules of the filarial worms have the
capacity to induce the production of anti-inflammatory
cytokines in host macrophages and change the phenotype
of these cells, while C. elegans cystatins do not have these
properties [13].
Since cystatin is a potential vaccine candidate [14], we
aimed to use C. elegans as expression system. A possible
advantage of using C. elegans as a host for expression of
filarial candidate vaccine antigens, compared to procaryo-
tic expression systems, is that post-translational modifica-
tions, which might be relevant for inducing protective
immune responses, would likely be conserved among the
nematodes. A. viteae cystatin is predicted to have one O-
i) Schematic representation of the genomic structure of Av17 (black and grey boxes represent the exons and the introns respectively)Figure 4
i) Schematic representation of the genomic structure of Av17 (black and grey boxes represent the exons and the introns 
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and the amino acid sequence of Av17 differs considerably
from the C. elegans cystatins except at the evolutionarily
conserved enzyme binding site [13]. Additionaly C. ele-
gans is a suitable system for evaluating its potential to
express this candidate vaccine antigen since detection of
the recombinant protein is possible by specific antibodies.
The expression of Av17 was detectable in transgenic C. ele-
gans lines transformed with the cDNA sequence by immu-
noblotting with anti-His antibodies and antibodies
specific for Av17 although, we were unable to purify the
protein using Ni-chelate affinity chromatography. This is
probably due to inaccessibility of the 6 His-leader in
lysates, an effect that is not uncommon for other recom-
binant proteins (own unpublished observations) and
depends probably on the interaction of the charged 6-His
tag with other stretches of the protein. An increase of the
expression of recombinant Av17 and the use of other puri-
fication methods could lead to production of C. elegans-
expressed Av17 in amounts amenable to further studies.
Furthermore, the reduction in the number of eggs devel-
oping to adults in worms expressing Av17 constitutively
suggests that the expression of protease inhibitor
interfered with proteases involved in the differentiation or
moulting of the worms.
In the C. elegans lines, 49gAv17, Av17 transcripts included
a part of the first intron. A sequence 152 bp downstream
in the first intron was recognised as the 5' splice donor site
and has the consensus sequence of AG/gt. It has a guanine
(g) at the +5 position (i.e., AG/gtttga), unlike the original
donor splice site of the first intron of Av17, which has a
cytosine (i.e., AG/gttacc). Introns 2, 3 and 4 have a gua-
nine at the +5 position (Table 1). Most C. elegans introns
[38] also have this conserved guanine at the +5 position
of the donor site including those of the homologous
cystatins. This suggests that the conserved G at the +5 posi-
tion in the donor splice site might be necessary to be rec-
ognised as intron 5' site in C. elegans. Most of the introns
(70%) of another gene of A. viteae, chitinase, have the
conserved G at the +5 position (Babila Tachu, personal
communication), but there is not enough information on
the organisation of the genes of this filarial species to
allow a conclusion on the specificity of exon/intron recog-
nition. The 3' splice intron acceptor sequence of uucag/A
was recognised correctly and the other introns were
spliced at the normal sites as in A. viteae. Earlier studies
with the expression of O. volvulus and H. contortus proteins
as GFP fusions in C. elegans showed that the introns were
spliced out normally [18,20]. Our results for the first time
suggest that the intron splicing and recognition may differ
among C. elegans and A. viteae at least with respect to
cystatin. Owing to such differences, the expression of
foreign genes in C. elegans might be more successful if
cDNA sequences of genes are used, as compared to the use
of genomic DNA.
Authors' contributions
SP carried out the cloning, promoter studies and expres-
sion in C. elegans and drafted the manuscript. BK worked
on the genomic sequence, analysed the promoter and
contributed to the manuscript. EL was involved in the
generation of transgenic C. elegans. SH contributed to the
revising of the manuscript. FT was involved in the genera-
tion of transgenic C. elegans. RL conceived the study, and
participated in its design and coordination and helped to
draft the manuscript. All authors read and approved the
final manuscript.
Acknowledgements
This study was supported by grant of the Deutsche Forschungsgemein-
schaft (Lu 325/8-1 to RL). We are grateful to Cora Burmeister (Bernhard 
Nocht Institute for Tropical Medicine) for the help with microinjection and 
to The CGC for providing C. elegans strains. We thank Jörg Hirzmann (Uni-
versity Giessen) for providing the genomic A. viteae library.
References
1. Maizels RM, Lawrence RA: Immunological tolerance: The key
feature in human filariasis?  Parasitol Today 1991, 7:271-276.
2. Nicklin MJ, Barrett AJ: Inhibition of cysteine proteinases and
dipeptidyl peptidase I by egg-white cystatin.  Biochem J 1984,
223:245-253.
3. Lustigman S, Brotman B, Huima T, Prince AM: Characterization of
an Onchocerca volvulus cDNA clone encoding a genus spe-
cific antigen present in infective larvae and adult worms.  Mol
Biochem Parasitol 1991, 45:65-75.
4. Hartmann S, Kyewski B, Sonnenburg B, Lucius R: A filarial cysteine
protease inhibitor down-regulates T cell proliferation and
enhances interleukin-10 production.  Eur J Immunol 1997,
27:2253-2260.
5. Maizels RM, Gomez-Escobar N, Gregory WF, Murray J, Zang X:
Immune evasion genes from filarial nematodes.  Int J Parasitol
2001, 31:889-898.
6. Manoury B, Gregory WF, Maizels RM, Watts C: Bm-CPI-2, a cysta-
tin homolog secreted by the filarial parasite Brugia malayi,
Table 1: Intron splice donor and acceptor sites of Av17 in A. viteae and in transgenic C. elegans.
Intron Size 5' Splice donor site of cystatin in A. 
viteae
5' Spilce donor site of A. viteae 
cystatin recog-nised in C. elegans
3' Splice acceptor site
1 221 bp ATACAG/gttacct CGAAAG/gtttga ttacag/GACCTG
2 220 bp AAAAAA/gtatgtt AAAAAA/gtatgtt tttcag/AGTTCA
3 1017 bp GATCAG/gtttgtt GATCAG/gtttgtt tttcag/ATTATCPage 9 of 10
(page number not for citation purposes)
Filaria Journal 2005, 4:9 http://www.filariajournal.com/content/4/1/9Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
inhibits class II MHC-restricted antigen processing.  Curr Biol
2001, 11:447-451.
7. Pfaff AW, Schulz-Key H, Soboslay PT, Taylor DW, MacLennan K,
Hoffmann WH: Litomosoides sigmodontis cystatin acts as an
immunomodulator during experimental filariasis.  Int J
Parasitol 2002, 32:171-178.
8. Dainichi T, Maekawa Y, Ishii K, Zhang T, Nashed BF, Sakai T,
Takashima M, Himeno K: Nippocystatin, a cysteine protease
inhibitor from Nippostrongylus brasiliensis, inhibits antigen
processing and modulates antigen-specific immune
response.  Infect Immun 2001, 69:7380-7386.
9. Schonemeyer A, Lucius R, Sonnenburg B, Brattig N, Sabat R, Schilling
K, Bradley J, Hartmann S: Modulation of human T cell responses
and macrophage functions by onchocystatin, a secreted pro-
tein of the filarial nematode Onchocerca volvulus.  J Immunol
2001, 167:3207-3215.
10. Hartmann S, Lucius R: Modulation of host immune responses by
nematode cystatins.  Int J Parasitol 2003, 33:1291-1302.
11. Hartmann S, Schonemeyer A, Sonnenburg B, Vray B, Lucius R:
Cystatins of filarial nematodes up-regulate the nitric oxide
production of interferon-gamma-activated murine
macrophages.  Parasite Immunol 2002, 24:253-262.
12. Vray B, Hartmann S, Hoebeke J: Immunomodulatory properties
of cystatins.  Cell Mol Life Sci 2002, 59:1503-1512.
13. Schierack P, Lucius R, Sonnenburg B, Schilling K, Hartmann S: Para-
site-specific immunomodulatory functions of filarial cystatin.
Infect Immun 2003, 71:2422-2429.
14. Abraham D, Leon O, Leon S, Lustigman S: Development of a
recombinant antigen vaccine against infection with the filar-
ial worm Onchocerca volvulus.  Infect Immun 2001, 69:262-270.
15. Aboobaker AA, Blaxter ML: Functional genomics for parasitic
nematodes and platyhelminths.  Trends Parasitol 2004,
20:178-184.
16. Shu L, Katholi CR, Higazi T, Unnasch TR: Analysis of the Brugia
malayi HSP70 promoter using a homologous transient
transfection system.  Mol Biochem Parasitol 2003, 128:67-75.
17. Jackstadt P, Wilm TP, Zahner H, Hobom G: Transformation of
nematodes via ballistic DNA transfer.  Mol Biochem Parasitol
1999, 103:261-266.
18. Krause S, Sommer A, Fischer P, Brophy PM, Walter RD, Liebau E:
Gene structure of the extracellular glutathione S-trans-
ferase from Onchocerca volvulus and its overexpression and
promoter analysis in transgenic Caenorhabditis elegans.  Mol
Biochem Parasitol 2001, 117:145-154.
19. Kampkotter A, Volkmann TE, de Castro SH, Leiers B, Klotz LO, John-
son TE, Link CD, Henkle-Duhrsen K: Functional analysis of the
glutathione S-transferase 3 from Onchocerca volvulus (Ov-
GST-3): a parasite GST confers increased resistance to oxi-
dative stress in Caenorhabditis elegans.  J Mol Biol 2003,
325:25-37.
20. Redmond DL, Clucas C, Johnstone IL, Knox DP: Expression of
Haemonchus contortus pepsinogen in Caenorhabditis
elegans.  Mol Biochem Parasitol 2001, 112:125-131.
21. Liu J, Dent JA, Beech RN, Prichard RK: Genomic organization of
an avermectin receptor subunit from Haemonchus contor-
tus and expression of its putative promoter region in
Caenorhabditis elegans.  Mol Biochem Parasitol 2004, 134:267-274.
22. Britton C, Redmond DL, Knox DP, McKerrow JH, Barry JD: Identi-
fication of promoter elements of parasite nematode genes in
transgenic Caenorhabditis elegans.  Mol Biochem Parasitol 1999,
103:171-181.
23. Hashmi S, Britton C, Liu J, Guiliano DB, Oksov Y, Lustigman S:
Cathepsin L is essential for embryogenesis and development
of Caenorhabditis elegans.  J Biol Chem 2002, 277:3477-3486.
24. Brenner S: The genetics of Caenorhabditis elegans.  Genetics
1974, 77:71-94.
25. Mello C, Fire A: DNA transformation.  Methods Cell Biol 1995,
48:451-482.
26. Kelly WG, Xu S, Montgomery MK, Fire A: Distinct requirements
for somatic and germline expression of a generally
expressed Caernorhabditis elegans gene.  Genetics 1997,
146:227-238.
27. C. elegans - A Practical Approach.  In Practical Approach Series
Edited by: Hope IA. , Oxford University Press; 1999. 
28. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of
proteins from polyacrylamide gels to nitrocellulose sheets:
procedure and some applications.  Proc Natl Acad Sci U S A 1979,
76:4350-4354.
29. Granato M, Schnabel H, Schnabel R: Genesis of an organ: molec-
ular analysis of the pha-1 gene.  Development 1994,
120:3005-3017.
30. Mount SM: A catalogue of splice junction sequences.  Nucleic
Acids Res 1982, 10:459-472.
31. Hoffmann E, Thiefes A, Buhrow D, Dittrich-Breiholz O, Schneider H,
Resch K, Kracht M: MEK1-dependent delayed expression of
Fos-related antigen-1 counteracts c-Fos and p65 NF-kappaB-
mediated interleukin-8 transcription in response to
cytokines or growth factors.  J Biol Chem 2005, 280:9706-9718.
32. Shaw PA, Chaparro O: The 5'-flanking sequence and regulatory
elements of the cystatin S gene.  Biochem Biophys Res Commun
1999, 261:705-711.
33. Khalife J, Godin C, Capron A: Transcriptional regulation of
Schistosoma mansoni calreticulin: possible role of AP-1.  Par-
asitology 1995, 111 ( Pt 4):469-475.
34. Lustigman S, Brotman B, Huima T, Prince AM, McKerrow JH: Molec-
ular cloning and characterization of onchocystatin, a
cysteine proteinase inhibitor of Onchocerca volvulus.  J Biol
Chem 1992, 267:17339-17346.
35. Franz M, Buttner DW: The fine structure of adult Onchocerca
volvulus. V. The digestive tract and the reproductive system
of the female worm.  Tropenmed Parasitol 1983, 34:155-161.
36. Fields C: Information content of Caenorhabditis elegans
splice site sequences varies with intron length.  Nucleic Acids
Res 1990, 18:1509-1512.Page 10 of 10
(page number not for citation purposes)
